The scientist behind the online cartoon RedPen/BlackPen explains how humor can build bridges between scientists and the public.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.

A multi-institutional team has developed a deep learning framework to identify novel molecules as drug candidates.

Arun Devaraj elected vice president of an international society representing the atom probe tomography researcher community.

Scientists have devised a way to engineer yeast to produce sustainable, eco-friendly commodity chemicals using computing power as a guide.

The nested nanoPOTS chip is the next generation of technology developed at PNNL to prepare single cells for proteomics.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Fundamental research conducted at the $90-million research facility will help the nation meet its clean energy goals.

One effort toward better batteries for electric vehicles is hitting overdrive, thanks to new findings about the desirable silicon anode.

PNNL data scientists are refining their artificial intelligence tools with COVID-19 data to advance therapeutics and treatments for a future pandemic.

Hypergraphs can more faithfully identify important genes in complex immune responses.

PNNL researchers are forming a clearer picture of how plant matter is transformed in the microbial gardens created by leaf-cutter ants.

The web-based tool, called PLATIPUS, is publicly available and interacts with publications available in the CovidScholar database.

Researchers have increased the lifetime of a promising electric vehicle battery to a record level.

New quantum chemistry pipeline can help predict the effects of bioengineering.

High-throughput biochemical assays targeting a vital viral protein identified one molecule out of more than 13,000 with promising antiviral activity against SARS-CoV-2.

New facility will accelerate energy storage innovation, increase clean energy adoption and grid resilience.